Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$2.6 - $5.16 $4,721 - $9,370
-1,816 Reduced 26.59%
5,013 $34,000
Q2 2022

Aug 15, 2022

BUY
$2.46 - $5.2 $11,087 - $23,436
4,507 Added 194.1%
6,829 $32,000
Q1 2022

May 12, 2022

SELL
$4.16 - $9.08 $18,224 - $39,779
-4,381 Reduced 65.36%
2,322 $11,000
Q4 2021

Feb 14, 2022

BUY
$7.65 - $11.38 $45,349 - $67,460
5,928 Added 764.9%
6,703 $57,000
Q3 2021

Nov 15, 2021

SELL
$9.93 - $13.59 $11,935 - $16,335
-1,202 Reduced 60.8%
775 $9,000
Q2 2021

Aug 16, 2021

SELL
$11.87 - $15.96 $39,681 - $53,354
-3,343 Reduced 62.84%
1,977 $25,000
Q1 2021

May 17, 2021

BUY
$13.87 - $21.04 $46,159 - $70,021
3,328 Added 167.07%
5,320 $73,000
Q4 2020

Feb 16, 2021

SELL
$17.03 - $22.45 $11,103 - $14,637
-652 Reduced 24.66%
1,992 $40,000
Q3 2020

Nov 16, 2020

BUY
$19.3 - $26.92 $51,029 - $71,176
2,644 New
2,644 $60,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.